NASDAQ$CRVL

CorVel Corporation · Q2 2022 earnings

Q2 2022 earnings · · Investor relations

Briefing

Corvel's revenue and earnings increased in Q2 2022.

CorVel Corporation reported an increase in revenues and earnings per share for the quarter ended September 30, 2021. Revenues increased to $158 million, and earnings per share rose to 88 cents.

  • Revenues for the quarter were $158 million, up from $136 million in the same quarter of the previous year.
  • Earnings per share for the quarter were 88 cents, compared to 65 cents in the same quarter of the prior year.
  • Continued development in new and existing business and improved operational efficiencies contributed to revenue growth.
  • Telehealth usage has stabilized at levels 38 times higher than pre-pandemic.

Headline financials

Total Revenue

$158M

Previous: $136M+16.0%
EPS (adj)

$0.29

Previous: $0.22+31.8%
Capital Expenditures

-$11.6M

Previous: -$6.94M-67.5%
Free Cash Flow

$4.46M

Previous: $4.93M-9.6%
Net Income

$16.1M

Previous: $11.9M+35.5%
Operating Income

$19.9M

Previous: $13.9M+42.6%
Gross Profit

$36.7M

Previous: $30.5M+20.2%
Cash & Equivalents

$131M

Previous: $106M+23.6%
Total Assets

$425M

Previous: $442M-3.8%
Stock-Based Comp

$1.36M

Previous: $1.24M+9.5%

Revenue & EPS history

CorVel · Revenue · Quarterly

$158M

Q2 2022+16%vs Q2 2021

Revenue by segment

CorVel · $249M total across 2 segments · Q4 2026

  • Patient management services
    $153M
  • Network solutions services
    $95.5M

Forward guidance

The company is focusing on patient engagement and ease of use in the healthcare and workers’ compensation processes and embracing opportunities for evolving health care models and providing tools to facilitate healthcare navigation.

Tailwinds

  • Continued development in new and existing business.
  • Improved operational efficiencies.
  • Expanded R&D efforts.
  • Quicker rate at which liquidity is converted into intellectual property.
  • Recent system enhancements increase the capacity, quality & consistency of our work product and the overall outcomes produced.

Headwinds

  • Risk that the impact of the COVID-19 pandemic on our business, results of operations and financial condition is greater than our initial assessment.
  • Risks and uncertainties described in the company’s filings with the Securities and Exchange Commission.
  • Factors described in the company’s filings with the Securities and Exchange Commission, including but not limited to “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended March 31, 2021
  • Factors described in the company’s filings with the Securities and Exchange Commission, including but not limited to the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2021.
  • The forward-looking statements in this press release speak only as of the date they are made.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q2 2022

Historical avgQ2 2022

-1.0%

Avg return

Earnings day

-0.3%

Avg return

5 days after

+0.4%

Avg return

30 days after

48%

30 / 63 earnings

Positive

+11.8%

Q1 2014

Best reaction

-26.1%

Q3 2026

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2026-0.7%+6.2%-0.9%
Q3 2026-26.1%-30.2%-21.4%
Q2 2026+4.1%+3.9%-3.8%
Q1 2026+1.2%-0.4%-0.6%
Q4 2025+2.3%+0.2%-9.1%
Q1 2025-0.3%-2.1%+4.0%
Q4 2024-0.3%+0.0%-11.5%
Q3 2025+1.7%+3.1%+5.4%
Q2 2025+3.0%+5.5%+10.4%
Q1 2024+5.9%+4.4%+5.8%
Q4 2023-2.0%-3.7%+0.2%
Q3 2023+6.1%+7.1%+5.3%
Q2 2023-4.8%-4.3%-6.3%
Q1 2023+1.6%-4.9%-6.8%
Q4 2022+1.6%-0.3%-1.1%
Q3 2022-9.9%-14.8%-5.7%
Q2 2022+0.4%+2.9%+5.7%
Q1 2022+8.1%+13.9%+18.7%
Q4 2021+4.0%+4.1%+9.7%
Q3 2021+1.4%+3.6%+2.1%
Q2 2021-7.0%-7.4%-0.2%
Q1 2021-2.9%+3.2%+7.8%
Q4 2020+8.9%+9.4%+14.4%
Q3 2020-3.2%-7.4%-23.9%
Q2 2020-0.7%-0.1%+4.1%
Q1 2020-8.4%-8.8%-7.4%
Q4 2019+4.6%+7.9%+23.0%
Q3 2019-0.5%+0.3%+1.2%
Q2 2019+5.6%+8.9%+25.6%
Q1 2019+1.0%+3.4%+8.5%
Q4 2018-3.2%-5.1%-1.1%
Q3 2018-3.8%-4.3%-11.2%
Q2 2018-3.8%-1.9%-5.6%
Q1 2018+1.8%+4.6%+9.1%
Q4 2017+4.0%+0.8%+1.8%
Q3 2017+2.7%+4.1%+8.4%
Q2 2017-8.0%-8.0%-8.2%
Q1 2017-7.7%-7.5%-19.3%
Q4 2016+8.2%+2.7%-9.7%
Q3 2016-2.3%
Q2 2016+1.4%
Q1 2016+3.8%
Q4 2015-10.6%
Q3 2015+4.2%
Q2 2015-0.1%
Q1 2015-1.2%
Q4 2014+0.0%
Q3 2014+2.4%
Q2 2014-1.7%
Q1 2014+11.8%
Q4 2012+1.3%
Q4 2013+4.5%
Q3 2013+1.6%
Q2 2013-3.8%
Q1 2013+1.7%
Q4 2010-0.7%
Q3 2012-3.4%
Q3 2011-3.4%
Q2 2012-1.7%
Q2 2011-12.3%
Q1 2012-12.3%
Q1 2011-12.3%
Q4 2011-12.3%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro